Could a 48-Week drug regimen cure hepatitis b in kids?
NCT ID NCT07231276
First seen Nov 17, 2025 · Last updated May 21, 2026 · Updated 21 times
Summary
This study tests whether a 48-week course of pegylated interferon alfa-2b can help teens and children (ages 3-17) with chronic hepatitis B achieve a clinical cure. About 113 participants will either receive the drug or standard care (no drug or nucleoside analogs). The goal is to see if the treatment clears the virus and improves immune response, though lifelong medication may still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanfang Hospital
Guangzhou, Guangdong, 510515, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.